Tyrosine hydroxylase deficiency (THD) is a rare genetic disorder that affects the production of certain neurotransmitters in the brain. It is an autosomal recessive disorder, meaning that an individual must inherit two copies of the mutated gene, one from each parent, to develop the condition.
Tyrosine hydroxylase is an enzyme that plays a crucial role in the production of several neurotransmitters, including dopamine, norepinephrine, and epinephrine. These neurotransmitters are essential for the normal functioning of the nervous system and are involved in various physiological processes, such as movement, mood regulation, and the body's response to stress.
The causes of Tyrosine Hydroxylase Deficiency can be attributed to mutations in the gene that provides instructions for making the tyrosine hydroxylase enzyme. These mutations can lead to a decrease in the enzyme's activity or its complete absence, resulting in a deficiency of the neurotransmitters it produces.
There are several known mutations that can cause THD, and the severity of the condition can vary depending on the specific mutation and its impact on enzyme function. Some mutations may result in a partial deficiency, while others may cause a complete absence of enzyme activity.
THD can be classified into two main types:
While the exact mechanisms leading to THD are not fully understood, certain factors may contribute to the development of the condition:
It is important to note that THD is a rare disorder, and its prevalence in the general population is relatively low. Genetic counseling and testing can help identify individuals who carry the mutated gene and provide information about the risk of passing it on to their children.